We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Novel Intraoperative Probe Developed for Cancer Surgery

By MedImaging International staff writers
Posted on 03 Jul 2017
Print article
Image: A depiction of the new multimodal probe in use during surgery, together with a Magnetic Resonance Imaging (MRI) scan of a brain cancer patient, showing the tumor in red (Photo courtesy of Frédéric Leblond and Kevin Petrecca).
Image: A depiction of the new multimodal probe in use during surgery, together with a Magnetic Resonance Imaging (MRI) scan of a brain cancer patient, showing the tumor in red (Photo courtesy of Frédéric Leblond and Kevin Petrecca).
An innovative intraoperative probe for detecting different types of tumor cells has been developed by researchers in Canada.

The multimodal hand-held Raman optical spectroscopy probe enables surgeons to detect nearly all cancer cells during brain surgery.

The scientists from the Polytechnique Montréal (Montréal, Canada), and two other hospitals and Universities developed the hand-held Raman spectroscopy probe. The device is now accurate, sensitive and specific enough for detecting brain, colon, lung, and skin cancer cells. During intraoperative testing the probe showed nearly 100% sensitivity for detecting cancer cells. Details of the breakthrough technology were published in the June 28, 2017, issue of the American Association for Cancer Research journal Cancer Research.

The unique feature of the new second-generation system is that it can be used in real-time, during a surgical procedure, to detect cancer cells. The multimodal probe uses intrinsic fluorescence spectroscopy, and diffuse-reflectance spectroscopy technologies. A randomized clinical trial is currently under way using the first-generation Raman spectroscopy probe for patients with gliomas, and will help researchers develop a protocol for a clinical trial of the new second-generation multimodal probe.

Chief of Neurosurgery, brain cancer researcher Dr. Petrecca, said, "Minimizing, or completely eliminating, the number of cancer cells during surgery is a critical part of cancer treatment, yet detecting cancer cells during surgery is challenging. Often it is impossible to visually distinguish cancer from normal brain, so invasive brain cancer cells frequently remain after surgery, leading to cancer recurrence and a worse prognosis. Surgically minimizing the number of cancer cells improves patient outcomes. A technology with extremely high accuracy is necessary, since surgeons will be using this information to help determine if tissues contain cancer cells or not."

Related Links:
Polytechnique Montréal

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Color Doppler Ultrasound System
KC20
New
Brachytherapy Planning System
Oncentra Brachy
Compact C-Arm with FPD
Arcovis DRF-C R21

Print article
Radcal

Channels

MRI

view channel
Image: PET/MRI can accurately classify prostate cancer patients (Photo courtesy of 123RF)

PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients

The Prostate Imaging Reporting and Data System (PI-RADS) is a five-point scale to assess potential prostate cancer in MR images. PI-RADS category 3 which offers an unclear suggestion of clinically significant... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.